
# HIPAA Breach Risk Assessment: IR-2026-0420-01

**Organization:** MedDefense Health Systems  
**Assessment date:** 2026-04-20, Sunday, 23:00 UTC (exercise scenario)  
**Prepared by:** Nishat Sultana Supty, Incident Response Analyst  
**Legal reviewer:** Helena Reyes, General Counsel — Pending  
**Final decision authority:** MedDefense's designated HIPAA Privacy Officer / authorized covered-entity decision-maker, with General Counsel review  
**Decision deadline:** Monday, 2026-04-21, before the 07:00 board briefing (exercise target)  
**Classification:** Confidential  
**Status:** Preliminary determination — legal approval pending

## 1. Incident Overview

MedDefense experienced unauthorized access to clinical records during a multi-host cybersecurity incident.

The forensic investigation identified:

- 1,847 reported Windows file-access events involving clinical PDF documents.
- Affected information categories: laboratory results and patient progress notes.
- File-access window: 2026-04-19 02:14:01Z–02:41:12Z.
- Account involved: `MEDDEFENSE\jdoe`.
- Source of remote authentication: CS-WS-101.
- Suspicious executable: `svchost32.exe`.
- C2-related communication from FILE-SVR-01 during the access window.
- One large proxy connection record containing 2,400,412 bytes, with transfer direction unverified.

**Evidence references:** FS-001, FS-002, FS-003, FS-004, PROXY-004, SYS-006.

The 1,847 figure represents reported file-access events, not a verified count of unique files or affected individuals.

The full forensic artifacts remain unavailable; findings are based on the preliminary investigation.

## 2. Regulatory Standard

Under 45 CFR §164.402, an impermissible use or disclosure of protected health information is presumed to be a breach unless the covered entity demonstrates a low probability that the information has been compromised, considering at least four required factors.

The analysis must also consider whether the information qualifies as unsecured PHI and whether a regulatory exception applies.

For this exercise, MedDefense is assessed as a HIPAA-covered healthcare organization. The encryption status of the accessed information has not been established.

## Factor 1 — Nature and Extent of PHI Involved

### Evidence

- FS-001 reports 1,847 file-access events over approximately 27 minutes.
- FS-002 identifies clinical laboratory reports and patient progress notes.
- The files are PDF documents located in clinical directories.
- The available filenames indicate patient-care information.
- The exact patient identifiers, diagnoses and number of unique affected individuals have not been verified.

### Conclusion

The potentially compromised information is sensitive clinical information.

Laboratory results and patient progress notes may contain identifiable health information and private details of medical treatment.

The likelihood of identification cannot be precisely measured without examining the original documents.

The nature of the information creates a substantial privacy concern.

**Risk assessment:** High concern.  
**Confidence:** High for clinical information categories; low for exact identifiers and patient count.

## Factor 2 — Unauthorized Person Who Used the PHI

### Evidence

- FS-003 records a Kerberos network logon to FILE-SVR-01 using `MEDDEFENSE\jdoe`.
- The logon originated from CS-WS-101.
- FS-002 associates clinical document reads with the suspicious executable `svchost32.exe`.
- SYS-001 links this executable to the malicious execution chain.
- The supplied analyst note states that `jdoe` is a scheduling coordinator without a legitimate clinical need to access the documents.
- PROXY-005 identifies C2-related connections involving affected systems.

### Conclusion

The records support unauthorized use of a legitimate account in connection with malicious software.

Although the account belongs to a MedDefense employee, the observed access was outside the documented clinical role and associated with suspicious executable activity.

The ultimate attacker identity is unknown.

There is no evidence that the unauthorized party was a trusted recipient subject to confidentiality obligations.

**Risk assessment:** High concern.  
**Confidence:** High for suspicious account use; moderate for attribution to an external attacker.

## Factor 3 — Whether PHI Was Actually Acquired or Viewed

### Evidence

- FS-001 reports 1,847 Event ID 4663 records with ReadData access.
- FS-002 identifies clinical PDF paths associated with those events.
- FS-003 links the access to the `jdoe` authentication session.
- FS-004 correlates the file-access window with suspicious external communications.
- PROXY-004 identifies a large connection record to the known C2 destination.
- The direction and content of the recorded transfer have not been verified.

### Conclusion

The evidence strongly supports unauthorized read access to clinical documents.

It does not prove that a human attacker personally viewed each document or that the documents were exported outside MedDefense.

However, the documented access and associated malicious activity mean that compromise cannot reasonably be dismissed solely because exfiltration has not been confirmed.

**Risk assessment:** High concern.  
**Confidence:** High for reported read access; low for confirmed external acquisition or exfiltration.

## Factor 4 — Extent of Risk Mitigation

### Evidence

- Task 2 selected selective isolation, C2 blocking and credential revocation.
- The proposed plan covers four compromised workstations and FILE-SVR-01.
- `MEDDEFENSE\jdoe` was identified for credential revocation.
- No live containment environment was provided.
- No evidence demonstrates completed host isolation, account revocation or C2 blocking.
- No attacker assurance, data recovery confirmation or verified deletion of acquired information is available.

### Conclusion

Containment actions have been planned, but their execution and effectiveness have not been demonstrated.

There is no verified mitigation that establishes the accessed information is no longer at risk.

Even successful future containment would not automatically reverse any earlier unauthorized access.

**Risk assessment:** High concern.  
**Confidence:** High that mitigation effectiveness is unverified.

---

## 3. Combined Four-Factor Assessment

| Factor | Finding | Confidence | Supports low probability? |
|---|---|---|---|
| 1. Nature and extent | Sensitive clinical laboratory results and patient notes | High for categories | No |
| 2. Unauthorized person | Suspicious use of legitimate account associated with malicious software | High / Moderate | No |
| 3. Acquired or viewed | Unauthorized read access supported; export unconfirmed | High / Low by outcome | No |
| 4. Mitigation | No verified effective containment or data-risk mitigation | High | No |

### Assessment Result

**The available evidence does not demonstrate a low probability that PHI was compromised.**

The four-factor assessment therefore fails to meet the low-probability threshold.

**Recommended determination: BREACH NOTIFICATION REQUIRED**, subject to final verification of HIPAA applicability, unsecured PHI status, any applicable exception and approval by the authorized MedDefense decision-maker.

A lack of confirmed exfiltration does not establish a low probability of compromise.

The organization bears the burden of documenting why notification would not be required.

## 4. Notification Obligations

If the final determination confirms a reportable breach of unsecured PHI:

1. Notify affected individuals without unreasonable delay and no later than 60 calendar days after discovery.
2. Notify the U.S. Department of Health and Human Services according to the number of affected individuals.
3. If 500 or more residents of a single state or jurisdiction are affected, assess the additional media-notification requirement.
4. Preserve the written risk assessment, forensic evidence and notification decisions.

The 1,847 access events cannot be treated as 1,847 unique affected individuals.

The actual individual count must be established through document and patient-identifier reconciliation.

The notification clock is based on the legally applicable discovery date, not automatically the date of the board briefing.

## 5. Final Determination and Approval

**Preliminary analyst determination:** Low probability of compromise is not demonstrated; notification is recommended.

**Legal reviewer:** Helena Reyes, General Counsel.

**Final determination authority:** MedDefense's designated HIPAA Privacy Officer or other authorized covered-entity decision-maker, with legal advice from Helena Reyes.

**Required decision point:** Before the Monday 07:00 board briefing, based on evidence available at that time.

**Next actions:**

- Validate the original 1,847 event records.
- Determine the number of unique affected individuals.
- Confirm patient identifiers and unsecured PHI status.
- Investigate the suspicious outbound transfer.
- Confirm containment and mitigation outcomes.
- Document the final notification decision and discovery date.

## 6. Final Assessment Statement

Based on the available forensic findings, MedDefense cannot establish a low probability that protected health information was compromised.

The assessment supports proceeding toward HIPAA breach notification, pending final legal and privacy approval.

**Status:** Preliminary determination — notification preparation recommended.
